Funding for this research was provided by:
Research for Patient Benefit Programme (PB-PG-0416-20008)
Research Trainees Coordinating Centre (CL-2019-17-001)
Received: 13 January 2022
Accepted: 24 March 2022
First Online: 11 April 2022
Ethics approval and consent to participate
: The study was approved by the National Research Ethics Service (15/NW/0778) written informed consent obtained from all patients.
: All participicants in this study provided written informed consent for the use of their data.
: Radhouene Neji and Karl Kunze are employees of Siemens Healthcare. The remaining authors have no relevant disclosures.